← Evidence map

ArticleScience translational medicine2011

A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice.

Natalya Lyubynska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

66 papers cite itlatest 60 shown

2011
…
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 21451123